MARCHF11-AS1

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, MARCHF11-AS1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MARCHF11-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where MARCHF11-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MARCHF11-AS1 is over-expressed in tumor.

PRAD and THCA are the cancer types where MARCHF11-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MARCHF11-AS1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
PRADAllAll+0.014.0402view →
THCAAllAll+0.006.0461view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MARCHF11-AS1–PRAD

Tumor-vs-normal expression box plot for MARCHF11-AS1 RNA in PRAD.

Open the PRAD breakdown →

Exploration